288 related articles for article (PubMed ID: 30884882)
1. Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management.
Li KL; Lee AY; Abuzeid WM
Med Sci (Basel); 2019 Mar; 7(3):. PubMed ID: 30884882
[TBL] [Abstract][Full Text] [Related]
2. The Role of Surgery in Management of Samter's Triad: A Systematic Review.
Adelman J; McLean C; Shaigany K; Krouse JH
Otolaryngol Head Neck Surg; 2016 Aug; 155(2):220-37. PubMed ID: 27071444
[TBL] [Abstract][Full Text] [Related]
3. Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis.
Spielman DB; Overdevest J; Gudis DA
World J Otorhinolaryngol Head Neck Surg; 2020 Dec; 6(4):207-213. PubMed ID: 33336175
[TBL] [Abstract][Full Text] [Related]
4. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
5. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
[TBL] [Abstract][Full Text] [Related]
6. Aspirin sensitivity does not compromise quality-of-life outcomes in patients with Samter's triad.
Jang DW; Comer BT; Lachanas VA; Kountakis SE
Laryngoscope; 2014 Jan; 124(1):34-7. PubMed ID: 23712910
[TBL] [Abstract][Full Text] [Related]
7. Aspirin desensitization for aspirin-exacerbated respiratory disease (Samter's Triad): a systematic review of the literature.
Xu JJ; Sowerby L; Rotenberg BW
Int Forum Allergy Rhinol; 2013 Nov; 3(11):915-20. PubMed ID: 23861151
[TBL] [Abstract][Full Text] [Related]
8. Update on the Management of Aspirin-Exacerbated Respiratory Disease.
Buchheit KM; Laidlaw TM
Allergy Asthma Immunol Res; 2016 Jul; 8(4):298-304. PubMed ID: 27126722
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
Rajan JP; Wineinger NE; Stevenson DD; White AA
J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
[TBL] [Abstract][Full Text] [Related]
10. Aspirin-exacerbated respiratory disease: evaluation and management.
Lee RU; Stevenson DD
Allergy Asthma Immunol Res; 2011 Jan; 3(1):3-10. PubMed ID: 21217919
[TBL] [Abstract][Full Text] [Related]
11. Aspirin-exacerbated respiratory disease: longitudinal assessment of a large cohort and implications of diagnostic delay.
Kshirsagar RS; Chou DW; Wei J; Liang J
Int Forum Allergy Rhinol; 2020 Apr; 10(4):465-473. PubMed ID: 32104978
[TBL] [Abstract][Full Text] [Related]
12. Dacryocystitis in a patient with Samter's triad.
Abdel-Aty A; Jin A; Manes RP; Khan M; Pointdujour-Lim R
Oman J Ophthalmol; 2022; 15(2):225-227. PubMed ID: 35937735
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease.
Adappa ND; Ranasinghe VJ; Trope M; Brooks SG; Glicksman JT; Parasher AK; Palmer JN; Bosso JV
Int Forum Allergy Rhinol; 2018 Jan; 8(1):49-53. PubMed ID: 29105347
[TBL] [Abstract][Full Text] [Related]
14. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
15. The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety.
Buchheit K; Bensko JC; Lewis E; Gakpo D; Laidlaw TM
World J Otorhinolaryngol Head Neck Surg; 2020 Dec; 6(4):203-206. PubMed ID: 33336174
[TBL] [Abstract][Full Text] [Related]
16. Samter's Triad to Aspirin-Exacerbated Respiratory Disease: Historical Perspective and Current Clinical Practice.
Krouse HJ; Krouse JH
ORL Head Neck Nurs; 2015; 33(4):14-8. PubMed ID: 26753248
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
Stevens WW; Peters AT; Hirsch AG; Nordberg CM; Schwartz BS; Mercer DG; Mahdavinia M; Grammer LC; Hulse KE; Kern RC; Avila P; Schleimer RP
J Allergy Clin Immunol Pract; 2017; 5(4):1061-1070.e3. PubMed ID: 28286156
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma.
Ibrahim C; Singh K; Tsai G; Huang D; Mazza J; Rotenberg B; Kim H; Moote DW
Allergy Asthma Clin Immunol; 2014; 10(1):64. PubMed ID: 25516728
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery.
Kim JE; Kountakis SE
Ear Nose Throat J; 2007 Jul; 86(7):396-9. PubMed ID: 17702319
[TBL] [Abstract][Full Text] [Related]
20. Samter's triad in childhood: a warning for those prescribing NSAIDs.
Ameratunga R; Randall N; Dalziel S; Anderson BJ
Paediatr Anaesth; 2013 Aug; 23(8):757-9. PubMed ID: 23782034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
